{"id":"W2980165771","doi":"10.1182/blood.v128.22.470.470","title":"Obinutuzumab or Rituximab Plus CHOP in Patients with Previously Untreated Diffuse Large B-Cell Lymphoma: Final Results from an Open-Label, Randomized Phase 3 Study (GOYA)","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency; Alberta Health Services","funders":"","keywords":"Medicine; Obinutuzumab; Rituximab; Internal medicine; Diffuse large B-cell lymphoma; CHOP; International Prognostic Index; Febrile neutropenia; Neutropenia; Gastroenterology; Oncology; Lymphoma; Surgery; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004170401,0.001493769,0.003516588,0.0003905936,0.0005811154,0.001705299,0.001056117,0.001610748,0.003398219],"category_scores_gemma":[0.002142629,0.0006886674,0.002860866,0.0007760108,0.001478017,0.001295493,0.0006132471,0.002923781,0.0006368485],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001165778,"about_ca_system_score_gemma":0.002181104,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00133498,"about_ca_topic_score_gemma":0.003573167,"domain_scores_codex":[0.9984688,0.0009664416,0.00008409071,0.000189604,0.00009498042,0.0001960771],"domain_scores_gemma":[0.9984163,0.000425101,0.0003419068,0.0001666718,0.0001077543,0.0005423047],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9591994,0.01068727,0.003051555,0.0004881839,0.00195399,0.0000679724,0.00009810875,0.0003471861,0.003178909,0.00006174826,0.0007976334,0.02006809],"study_design_scores_gemma":[0.8955238,0.09571575,0.006357855,0.00004288712,0.0008650814,0.00005664081,0.00003797545,0.0002559546,0.0002492515,0.0001124457,0.0007657472,0.00001663861],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9848698,0.006388523,0.0007618387,0.0005598549,0.000253336,0.004340203,0.001479846,0.00008779081,0.001258686],"genre_scores_gemma":[0.9843529,0.003431997,0.001902092,0.001417844,0.0003701952,0.004620204,0.002805412,0.00004152039,0.001057824],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004170401,"threshold_uncertainty_score":0.02205545,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02549305422727246,"score_gpt":0.2949686066207464,"score_spread":0.2694755523934739,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}